Target-  | 
MechanismHepatitis C virus replication inhibitors   | 
 | 
 | 
 | 
Inactive Indication-  | 
Drug Highest PhasePhase 1  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
100 Clinical Results associated with MIP-11 LLC
0  Patents (Medical) associated with MIP-11 LLC
100 Deals associated with MIP-11 LLC
100 Translational Medicine associated with MIP-11 LLC